Caldarone, Barbara J. et al
"The Novel Triple Reuptake Inhibitor JZAD-IV-22 Exhibits an Antidepressant Pharmacological Profile without Locomotor Stimulant or Sensitization Properties." Journal of Pharmacology and Experimental Therapeutics
335.3
(2010):
762-770.
Web. 19 April. 2024.